Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by 1wascallywabbiton Feb 22, 2017 9:25am
239 Views
Post# 25876295

RE:RE:RE:RBC

RE:RE:RE:RBCMost definitely it is, and the chart trend line does show that some improved, but it is not clear to me if this is the chart from  November or present time. I was just speaking of the wording in the NR from Management. In November they clearly stated the Improvement word. Today they didn't. That is why RBC noted the difference, as I did. It does not mean the data is not good, as it clearly is, and will cause the majors to take notice. It is a very positive NR, but I just noted that little change, as RBC did as well.
Bullboard Posts